| 000 | 01793 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512005229.0 | ||
| 264 | 0 | _c19891106 | |
| 008 | 198911s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(89)90061-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetrillo, P | |
| 245 | 0 | 0 |
_aRegional variations in binding capacities at mu-, delta- and kappa-opioid sites in membrane suspensions from rabbit brain. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJul 1989 |
||
| 300 |
_a213-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnalgesics _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzomorphans _xmetabolism |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 | _aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- |
| 650 | 0 | 4 |
_aEnkephalin, Leucine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEnkephalin, Leucine-2-Alanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEnkephalins _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembranes _xmetabolism |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Opioid, delta |
| 650 | 0 | 4 | _aReceptors, Opioid, kappa |
| 650 | 0 | 4 | _aReceptors, Opioid, mu |
| 700 | 1 | _aLa Regina, A | |
| 700 | 1 | _aSbacchi, M | |
| 700 | 1 | _aTavani, A | |
| 700 | 1 | _aRobson, L E | |
| 700 | 1 | _aKosterlitz, H W | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 166 _gno. 2 _gp. 213-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(89)90061-7 _zAvailable from publisher's website |
| 999 |
_c2557655 _d2557655 |
||